157 related articles for article (PubMed ID: 2461405)
1. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains.
Lebel B; Bousquet J; Morel A; Chanal I; Godard P; Michel FB
J Allergy Clin Immunol; 1988 Nov; 82(5 Pt 1):869-77. PubMed ID: 2461405
[TBL] [Abstract][Full Text] [Related]
2. Nasal challenge with pollen grains, skin-prick tests and specific IgE in patients with grass pollen allergy.
Bousquet J; Lebel B; Dhivert H; Bataille Y; Martinot B; Michel FB
Clin Allergy; 1987 Nov; 17(6):529-36. PubMed ID: 3436032
[TBL] [Abstract][Full Text] [Related]
3. Mediator release after allergic and physical nasal challenges.
Norman PS; Naclerio RM; Creticos PS; Togias A; Lichtenstein LM
Int Arch Allergy Appl Immunol; 1985; 77(1-2):57-63. PubMed ID: 2409027
[TBL] [Abstract][Full Text] [Related]
4. Antiallergic activity of H1-receptor antagonists assessed by nasal challenge.
Bousquet J; Lebel B; Chanal I; Morel A; Michel FB
J Allergy Clin Immunol; 1988 Nov; 82(5 Pt 1):881-7. PubMed ID: 2461406
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunologic reactivity of patients allergic to grass pollens and to multiple pollen species. I. Clinical and immunologic characteristics.
Bousquet J; Hejjaoui A; Becker WM; Cour P; Chanal I; Lebel B; Dhivert H; Michel FB
J Allergy Clin Immunol; 1991 Mar; 87(3):737-46. PubMed ID: 2005328
[TBL] [Abstract][Full Text] [Related]
6. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine.
Baroody FM; Ford S; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
Am J Respir Crit Care Med; 1994 Jun; 149(6):1457-65. PubMed ID: 7516250
[TBL] [Abstract][Full Text] [Related]
7. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
[TBL] [Abstract][Full Text] [Related]
8. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
Creticos PS; Adkinson NF; Kagey-Sobotka A; Proud D; Meier HL; Naclerio RM; Lichtenstein LM; Norman PS
J Clin Invest; 1985 Dec; 76(6):2247-53. PubMed ID: 2416777
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin D2 measurement in nasal secretions is not a reliable marker for mast cell activation in atopic patients.
Wang DY; Smitz J; Clement P
Clin Exp Allergy; 1995 Dec; 25(12):1228-34. PubMed ID: 8821304
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy.
Bousquet J; Maasch H; Martinot B; Hejjaoui A; Wahl R; Michel FB
J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):439-46. PubMed ID: 3170992
[TBL] [Abstract][Full Text] [Related]
11. Effects of intensity of early response to allergen on the late phase of both the nose and skin.
Small P; Biskin N; Barrett D
Ann Allergy; 1994 Sep; 73(3):252-8. PubMed ID: 8092561
[TBL] [Abstract][Full Text] [Related]
12. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
[TBL] [Abstract][Full Text] [Related]
13. The response to nasal allergen provocation with grass pollen is reduced in patients with chronic rhinosinusitis with nasal polyposis and grass sensitization.
Calus L; Devuyst L; Van Zele T; De Ruyck N; Derycke L; Bachert C; Gevaert P
Clin Exp Allergy; 2016 Apr; 46(4):555-63. PubMed ID: 26661927
[TBL] [Abstract][Full Text] [Related]
14. The pathophysiology of rhinitis. V. Sources of protein in allergen-induced nasal secretions.
Raphael GD; Igarashi Y; White MV; Kaliner MA
J Allergy Clin Immunol; 1991 Jul; 88(1):33-42. PubMed ID: 1712803
[TBL] [Abstract][Full Text] [Related]
15. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement.
Togias AG; Naclerio RM; Proud D; Fish JE; Adkinson NF; Kagey-Sobotka A; Norman PS; Lichtenstein LM
J Clin Invest; 1985 Oct; 76(4):1375-81. PubMed ID: 2414318
[TBL] [Abstract][Full Text] [Related]
16. The nasal response to histamine challenge: effect of the pollen season and immunotherapy.
Majchel AM; Proud D; Freidhoff L; Creticos PS; Norman PS; Naclerio RM
J Allergy Clin Immunol; 1992 Jul; 90(1):85-91. PubMed ID: 1629510
[TBL] [Abstract][Full Text] [Related]
17. Precision of conjunctival provocation tests in right and left eyes.
Aichane A; Campbell AM; Chanal I; Richard MC; Arnaud B; Michel FB; Bousquet J
J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):49-55. PubMed ID: 8335854
[TBL] [Abstract][Full Text] [Related]
18. Mediator release is altered in immunotherapy-treated patients: a 4-year study.
Dokic D; Nethe A; Kleine-Tebbe J; Kunkel G; Baumgarten CR
Allergy; 1996 Nov; 51(11):796-803. PubMed ID: 8947337
[TBL] [Abstract][Full Text] [Related]
19. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.
Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M
J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796
[TBL] [Abstract][Full Text] [Related]
20. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
Pipkorn U; Proud D; Lichtenstein LM; Schleimer RP; Peters SP; Adkinson NF; Kagey-Sobotka A; Norman PS; Naclerio RM
J Clin Invest; 1987 Oct; 80(4):957-61. PubMed ID: 2443539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
